AVITA Medical, Inc.
RCEL
$5.16
-$0.14-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.59% | 28.49% | -5.28% | 17.50% | -164.09% |
| Total Depreciation and Amortization | 27.38% | 31.94% | 51.96% | 0.49% | 8.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.49% | -39.13% | 156.79% | -35.87% | 194.16% |
| Change in Net Operating Assets | 132.31% | -131.56% | 4,735.29% | 99.18% | -208,266.67% |
| Cash from Operations | -27.57% | -12.02% | 43.55% | 38.75% | -92.06% |
| Capital Expenditure | 86.29% | 57.13% | -41.78% | -131.21% | -287.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.09% | -63.39% | -26.05% | -6.96% | 128.44% |
| Cash from Investing | 335.69% | -66.58% | -40.52% | -17.48% | 126.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -64.45% | 1.39% | 18.61% | 34.55% | -5.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -64.45% | 1.39% | 18.61% | 34.55% | -98.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.87% | -486.60% | 136.93% | 109.70% | 82.02% |